TAOP Faces Nasdaq Bid-Price Compliance Window With Potential Delisting Risk
Oct 14, 2026, 5:45 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
TAOP faces a real delisting risk if it cannot regain the $1 bid price within 180 days, which historically leads to liquidity decline, wider spreads, and potential forced capital restructuring. Similar microcaps under $1 often see material negative price reactions unless a credible cure plan (e.g., reverse split) is announced and executed.
AI summary
What happened, with direct paths to the underlying reporting
Taoping disclosed Nasdaq notified it of non-compliance with the $1 minimum bid price, triggering a 180-day cure through April 12, 2027. The company may pursue a reverse split to regain compliance; failure could lead to delisting. The news adds execution risk and potential near-term pressure on TAOP's liquidity and trading volume.
Nasdaq notified TAOP of bid price below $1 for 30+ trading days.
TAOP has 180 days to regain compliance, ending April 12, 2027.
Delisting risk if $0.10 threshold breached for 10 days.
Trading stays live; no immediate listing change.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event